On September 1, BWX Technologies Inc rose 5.01% in regular trading, trading at $160.09/share, with turnover of approximately $149 million.

The rally extends momentum following the company's selection to deploy its nuclear technology for the US Army's Janus program. Under the contract announced late August, BWX Technologies will leverage its proprietary nuclear capabilities for the defense initiative, reinforcing its position as a key supplier to the US military.

The Janus award caps a series of positive developments for the company. In July, BWX Technologies completed the acquisition of Precision Components Group (PCG), a US-based manufacturer of complex heavy-walled and heat-transfer components, adding over 500,000 square feet of heavy-manufacturing capacity and roughly $125 million in annual revenue. In June, the company licensed its mPower small modular reactor technology to Applied Atomics for commercial deployment in the US, Canada, and other markets, while retaining full IP ownership and exclusive manufacturing rights. The company also notified the NRC of plans to apply for a uranium enrichment license in early next year. Full-year adjusted EPS guidance of $4.70-$4.80 remains in line with consensus estimates.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)